SynergyMed
Medical Devices for Human and Veterinary Cancer Treatment
Company Overview
Snapshot
Founded in January 2018 by Anan Copty, SynergyMed operates with 11–50 employees. The company is currently in a Pre-Funding stage, focusing on the development of medical devices for cancer treatment.
Business overview
SynergyMed is an early-stage startup developing medical devices for cancer treatment in both human and veterinary applications. The company's core technology focuses on a non-invasive solution designed to replace surgical resection of cancerous tumors. This system aims to ablate and destroy tumors quickly and effectively without damaging healthy tissue. SynergyMed operates within the Health Tech & Life Sciences sector, specifically in Medical Devices and Medical Treatment & Therapeutics, targeting healthcare providers and pet owners.
Company Intelligence Q&A
- What is SynergyMed's primary focus?
- SynergyMed is developing medical devices for cancer treatment in human and veterinary applications.
- When was SynergyMed founded?
- SynergyMed was founded in January 2018.
- Who founded SynergyMed?
- SynergyMed was founded by Anan Copty.
- What is SynergyMed's current product stage?
- SynergyMed is currently in the R&D product stage, focusing on developing its non-invasive solution for tumor ablation.
- What markets does SynergyMed target?
- SynergyMed targets geomarkets including Europe, Asia, and North America.